Prab: CSV import

2025-04-06T06:11:39Z

CSV import

← Older revision		Revision as of 06:11, 6 April 2025
Line 1:		Line 1:
			{{SI}}
			{{Infobox medical condition
			\| name = Progressive bifocal chorioretinal atrophy
			\| image = [[File:Autosomal_dominant_-_en.svg\|200px]]
			\| caption = Progressive bifocal chorioretinal atrophy is inherited in an [[autosomal dominant]] pattern.
			\| synonyms = PBCRA
			\| specialty = [[Ophthalmology]]
			\| symptoms = Progressive vision loss, [[night blindness]], [[peripheral vision]] loss
			\| onset = Childhood or early adulthood
			\| duration = Lifelong
			\| causes = Genetic mutation
			\| risks = Family history of the condition
			\| diagnosis = [[Ophthalmic examination]], [[genetic testing]]
			\| differential = [[Retinitis pigmentosa]], [[Stargardt disease]]
			\| treatment = No cure, supportive care, [[low vision aids]]
			\| prognosis = Progressive vision loss
			\| frequency = Rare
			}}
	'''Progressive Bifocal Chorioretinal Atrophy''' (PBCRA) is a rare, inherited eye disorder characterized by progressive loss of vision due to atrophy of the [[choroid]] and [[retina]]. This condition typically manifests in two distinct areas of the eye, leading to its classification as "bifocal." The disease progression leads to a gradual deterioration of the [[photoreceptors]], which are critical for vision, particularly affecting the central and peripheral visual fields.		'''Progressive Bifocal Chorioretinal Atrophy''' (PBCRA) is a rare, inherited eye disorder characterized by progressive loss of vision due to atrophy of the [[choroid]] and [[retina]]. This condition typically manifests in two distinct areas of the eye, leading to its classification as "bifocal." The disease progression leads to a gradual deterioration of the [[photoreceptors]], which are critical for vision, particularly affecting the central and peripheral visual fields.

	==Symptoms==		==Symptoms==
	The primary symptoms of Progressive Bifocal Chorioretinal Atrophy include a progressive loss of visual acuity, difficulties with night vision, and a narrowing of the visual field. Patients may also experience photophobia, or light sensitivity, and, in some cases, complete blindness. The onset of symptoms usually occurs in childhood or early adolescence.		The primary symptoms of Progressive Bifocal Chorioretinal Atrophy include a progressive loss of visual acuity, difficulties with night vision, and a narrowing of the visual field. Patients may also experience photophobia, or light sensitivity, and, in some cases, complete blindness. The onset of symptoms usually occurs in childhood or early adolescence.

	==Causes==		==Causes==
	PBCRA is a genetic disorder, inherited in an autosomal recessive manner. This means that the condition occurs when an individual inherits two copies of the mutated gene, one from each parent. The specific genes involved in PBCRA have not been fully identified, making genetic counseling and prediction of the disease challenging.		PBCRA is a genetic disorder, inherited in an autosomal recessive manner. This means that the condition occurs when an individual inherits two copies of the mutated gene, one from each parent. The specific genes involved in PBCRA have not been fully identified, making genetic counseling and prediction of the disease challenging.

	==Diagnosis==		==Diagnosis==
	Diagnosis of Progressive Bifocal Chorioretinal Atrophy is primarily based on clinical examination, including a detailed patient history and a comprehensive eye examination. Imaging techniques such as [[Fundus photography]], [[Fluorescein angiography]], and [[Optical Coherence Tomography]] (OCT) are crucial for visualizing the extent of chorioretinal atrophy and confirming the diagnosis. Genetic testing may also be recommended to identify the presence of specific genetic mutations associated with the condition, although the availability of such testing is limited due to the rarity of the disease.		Diagnosis of Progressive Bifocal Chorioretinal Atrophy is primarily based on clinical examination, including a detailed patient history and a comprehensive eye examination. Imaging techniques such as [[Fundus photography]], [[Fluorescein angiography]], and [[Optical Coherence Tomography]] (OCT) are crucial for visualizing the extent of chorioretinal atrophy and confirming the diagnosis. Genetic testing may also be recommended to identify the presence of specific genetic mutations associated with the condition, although the availability of such testing is limited due to the rarity of the disease.

	==Treatment==		==Treatment==
	There is currently no cure for Progressive Bifocal Chorioretinal Atrophy. Treatment focuses on managing symptoms and maximizing the patient's remaining vision. This may include the use of low vision aids, such as magnifying glasses or specialized electronic devices, and adaptive training to help individuals adjust to their visual limitations. Regular monitoring by an ophthalmologist is essential to address any complications that may arise, such as the development of [[neovascularization]] or secondary [[glaucoma]].		There is currently no cure for Progressive Bifocal Chorioretinal Atrophy. Treatment focuses on managing symptoms and maximizing the patient's remaining vision. This may include the use of low vision aids, such as magnifying glasses or specialized electronic devices, and adaptive training to help individuals adjust to their visual limitations. Regular monitoring by an ophthalmologist is essential to address any complications that may arise, such as the development of [[neovascularization]] or secondary [[glaucoma]].

	==Prognosis==		==Prognosis==
	The prognosis for individuals with Progressive Bifocal Chorioretinal Atrophy varies depending on the severity of the condition and the age at onset. While the disease is progressive, leading to a gradual decline in vision, many patients retain a degree of functional vision well into adulthood. Early diagnosis and intervention can help to optimize visual function and improve quality of life.		The prognosis for individuals with Progressive Bifocal Chorioretinal Atrophy varies depending on the severity of the condition and the age at onset. While the disease is progressive, leading to a gradual decline in vision, many patients retain a degree of functional vision well into adulthood. Early diagnosis and intervention can help to optimize visual function and improve quality of life.

	[[Category:Eye diseases]]		[[Category:Eye diseases]]
	[[Category:Genetic disorders]]		[[Category:Genetic disorders]]
	[[Category:Rare diseases]]		[[Category:Rare diseases]]

	{{rarediseases}}		{{rarediseases}}
	~~<gallery>~~
	~~File:Autosomal_dominant_-_en.svg~~
	~~</gallery>~~

Prab: CSV import

2025-02-16T22:13:25Z

CSV import

← Older revision		Revision as of 22:13, 16 February 2025
Line 21:		Line 21:

	{{rarediseases}}		{{rarediseases}}
			<gallery>
			File:Autosomal_dominant_-_en.svg
			</gallery>

Prab: CSV import

2024-03-30T04:22:04Z

CSV import

New page

'''Progressive Bifocal Chorioretinal Atrophy''' (PBCRA) is a rare, inherited eye disorder characterized by progressive loss of vision due to atrophy of the [[choroid]] and [[retina]]. This condition typically manifests in two distinct areas of the eye, leading to its classification as "bifocal." The disease progression leads to a gradual deterioration of the [[photoreceptors]], which are critical for vision, particularly affecting the central and peripheral visual fields.

==Symptoms==
The primary symptoms of Progressive Bifocal Chorioretinal Atrophy include a progressive loss of visual acuity, difficulties with night vision, and a narrowing of the visual field. Patients may also experience photophobia, or light sensitivity, and, in some cases, complete blindness. The onset of symptoms usually occurs in childhood or early adolescence.

==Causes==
PBCRA is a genetic disorder, inherited in an autosomal recessive manner. This means that the condition occurs when an individual inherits two copies of the mutated gene, one from each parent. The specific genes involved in PBCRA have not been fully identified, making genetic counseling and prediction of the disease challenging.

==Diagnosis==
Diagnosis of Progressive Bifocal Chorioretinal Atrophy is primarily based on clinical examination, including a detailed patient history and a comprehensive eye examination. Imaging techniques such as [[Fundus photography]], [[Fluorescein angiography]], and [[Optical Coherence Tomography]] (OCT) are crucial for visualizing the extent of chorioretinal atrophy and confirming the diagnosis. Genetic testing may also be recommended to identify the presence of specific genetic mutations associated with the condition, although the availability of such testing is limited due to the rarity of the disease.

==Treatment==
There is currently no cure for Progressive Bifocal Chorioretinal Atrophy. Treatment focuses on managing symptoms and maximizing the patient's remaining vision. This may include the use of low vision aids, such as magnifying glasses or specialized electronic devices, and adaptive training to help individuals adjust to their visual limitations. Regular monitoring by an ophthalmologist is essential to address any complications that may arise, such as the development of [[neovascularization]] or secondary [[glaucoma]].

==Prognosis==
The prognosis for individuals with Progressive Bifocal Chorioretinal Atrophy varies depending on the severity of the condition and the age at onset. While the disease is progressive, leading to a gradual decline in vision, many patients retain a degree of functional vision well into adulthood. Early diagnosis and intervention can help to optimize visual function and improve quality of life.

[[Category:Eye diseases]]
[[Category:Genetic disorders]]
[[Category:Rare diseases]]

{{rarediseases}}

Progressive bifocal chorioretinal atrophy - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import